What Silverarc Capital Management, LLC reported holding on Form 13F for the quarter ended Jun 30, 2026.
CIK 1816307 · Filed Aug 13, 2026
Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR
| 501K |
| +40.0% |
| $52.4M |
| 5.4% |
COGTCogent Biosciences, Inc. | 1.3M | −2.5% | $49.6M | 5.2% |
URGNUroGen Pharma Ltd. | 1.3M | −13.4% | $47.9M | 5% |
IMNMImmunome Inc. | 2M | +9.0% | $42.7M | 4.4% |
DNTHDianthus Therapeutics, Inc. | 390K | −40.4% | $38M | 4% |
RYTMRhythm Pharmaceuticals, Inc. | 311.5K | +1.8% | $34.6M | 3.6% |
ORKAOruka Therapeutics, Inc. | 352.8K | +133.8% | $33.6M | 3.5% |
GLUEMonte Rosa Therapeutics, Inc. | 1.1M | −44.6% | $26.8M | 2.8% |
SNDXSyndax Pharmaceuticals Inc | 1.2M | +36.6% | $26.5M | 2.8% |
ELVNEnliven Therapeutics, Inc. | 489.4K | New | $24.8M | 2.6% |
IMVTImmunovant, Inc. | 619.1K | +49.5% | $23.9M | 2.5% |
ERASErasca, Inc. | 1.3M | −31.8% | $23.1M | 2.4% |
SGMTSagimet Biosciences Inc. | 2.9M | New | $22.6M | 2.4% |
ABVXAbivax S.A. | 169.6K | −43.9% | $22.6M | 2.3% |
PRAXPraxis Precision Medicines, Inc. | 65.7K | −8.2% | $22M | 2.3% |
KODKodiak Sciences Inc. | 546.3K | −44.9% | $21.3M | 2.2% |
ARK ETF TRPUTPut option | 500K | New | $21M | 2.2% |
DFTXDefinium Therapeutics, Inc. | 400K | New | $18.8M | 2% |
VCYTVeracyte, Inc. | 318K | +77.0% | $18.7M | 1.9% |
SYNDAX PHARMACEUTICALS INCCALLCall option | 693.6K | +116.8% | $15.2M | 1.6% |
GHGuardant Health, Inc. | 99.8K | +1.3% | $15M | 1.6% |
CCCCC4 Therapeutics, Inc. | 3M | +58.6% | $14.2M | 1.5% |
ZBIOZenas BioPharma, Inc. | 509.8K | −55.1% | $12.9M | 1.3% |
TRVITrevi Therapeutics, Inc. | 678.1K | +32.7% | $12.6M | 1.3% |
HLXCHelix Acquisition Corp. III | 1.2M | −2.6% | $12.5M | 1.3% |
ALXOALX Oncology Holdings Inc | 5.7M | New | $11.9M | 1.2% |
MANEVeradermics, Inc | 95K | New | $11.7M | 1.2% |
XENEXenon Pharmaceuticals Inc. | 186.8K | −5.5% | $11.3M | 1.2% |
AVLNAvalyn Pharma Inc. | 330.5K | New | $10.9M | 1.1% |
BIIBBiogen Inc. | 48.1K | −5.6% | $10.4M | 1.1% |
ACRSAclaris Therapeutics, Inc. | 1.9M | New | $10.3M | 1.1% |
CERSCerus Corp | 3.5M | +9.3% | $10.1M | 1.1% |
AVTXAvalo Therapeutics, Inc. | 500.4K | New | $9.2M | 1% |
BNTCBenitec Biopharma Inc. | 679.8K | −5.3% | $9.1M | 0.9% |
PCVXVaxcyte, Inc. | 145K | +0.0% | $8.4M | 0.9% |
WGSGeneDx Holdings Corp. | 122.3K | New | $8.4M | 0.9% |
SVRASavara Inc | 1.4M | −5.3% | $8.3M | 0.9% |
OVIDOvid Therapeutics Inc. | 3.1M | +210.1% | $8.3M | 0.9% |
ORICOric Pharmaceuticals, Inc. | 738.9K | −32.8% | $8M | 0.8% |
ORIC PHARMACEUTICALS INCCALLCall option | 682.6K | New | $7.4M | 0.8% |
MONTE ROSA THERAPEUTICS INCCALLCall option | 300K | New | $7.3M | 0.8% |
CMPSCOMPASS Pathways plc | 503.4K | +67.8% | $7.1M | 0.7% |
CGENCompugen Ltd | 3.2M | −4.0% | $6.8M | 0.7% |
SLDBSolid Biosciences Inc. | 668.5K | New | $6.7M | 0.7% |
ABIVAX SACALLCall option | 50K | New | $6.7M | 0.7% |
IBIOiBio, Inc. | 3.5M | +1,457.7% | $6.2M | 0.6% |
IRONDisc Medicine, Inc. | 82.8K | −57.8% | $6.1M | 0.6% |
ALKSAlkermes plc. | 113.5K | −75.3% | $5.9M | 0.6% |
SYRESpyre Therapeutics, Inc. | 60K | −67.9% | $5.3M | 0.6% |
ARTVArtiva Biotherapeutics, Inc. | 525K | New | $5.1M | 0.5% |
CTNMContineum Therapeutics, Inc. | 296.1K | −1.9% | $4.9M | 0.5% |
QUREuniQure N.V. | 105K | New | $4.8M | 0.5% |
RACCResearch Alliance Corp III | 360K | New | $3.9M | 0.4% |
ABEOAbeona Therapeutics Inc. | 610.4K | −5.9% | $3.8M | 0.4% |
INSMINSMED Inc | 34.4K | −3.9% | $3.7M | 0.4% |
KPTIKaryopharm Therapeutics Inc. | 297.5K | New | $2.9M | 0.3% |
KYMERA THERAPEUTICS INCPUTPut option | 25K | New | $2.9M | 0.3% |
CAMPCamp4 Therapeutics Corp | 653.6K | ±0% | $2.9M | 0.3% |
ELUTElutia Inc. | 2.2M | −12.2% | $2.1M | 0.2% |
RVMDRevolution Medicines, Inc. | 10K | New | $1.9M | 0.2% |
SIONSionna Therapeutics, Inc. | 42.5K | +7.8% | $1.9M | 0.2% |
ABSCI CORPORATIONPUTPut option | 157.6K | New | $1.8M | 0.2% |
TELATELA Bio, Inc. | 2.1M | −5.4% | $1.6M | 0.2% |
ACHVAchieve Life Sciences, Inc. | 227.2K | New | $1.5M | 0.2% |
FULCRUM THERAPEUTICS INCCALLCall option | 391.9K | ±0% | $1.4M | 0.1% |
GUTSFractyl Health, Inc. | 1.6M | −3.7% | $1.3M | 0.1% |
CNTBConnect Biopharma Holdings Ltd | 545K | New | $1.3M | 0.1% |
CBIOCrescent Biopharma, Inc. | 59.1K | −54.7% | $1.1M | 0.1% |
CLRBCellectar Biosciences, Inc. | 321.7K | New | $894.4K | 0.1% |
FHTXFoghorn Therapeutics Inc. | 46K | New | $224.4K | 0.1% |
ADGMAdagio Medical Holdings, Inc. | 224.4K | −11.0% | $146.2K | 0.1% |
RCKTWRocket Pharmaceuticals, Inc. | 104.8K | ±0% | $356 | 0% |
